RPID Rapid Micro Biosystems, Inc

Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.

$18.99  -0.93 (-4.65%)
As of 10/25/2021 15:59:54 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Medical Devices
Index country:  USA
Country of incorporation:  USA
IPO date:  01/24/2017
Outstanding shares:  34,178,636
Average volume:  85,260
Market cap:   $681,522,002
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    75340L104
ISIN:        US75340L1044
Valuation   (See tab for details)
PE ratio:   -13.75
PB ratio:   9.54
PS ratio:   0.00
Return on equity:   -77.17%
Net income %:   -277.26%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy